Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions

被引：1
|
作者：
Zamarin, Dmitriy [1 ]
Palese, Peter [1 ]
机构：
[1] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA
来源：
FUTURE MICROBIOLOGY | 2012年 / 7卷 / 03期
关键词：
apoptosis; cancer; immunotherapy; interferon; NDV; oncolytic; TUMOR-CELL VACCINE; EHRLICH ASCITES TUMOR; ACTIVE SPECIFIC IMMUNOTHERAPY; HEMAGGLUTININ-NEURAMINIDASE PROTEIN; BISPECIFIC FUSION PROTEIN; APOPTOSIS-INDUCING LIGAND; SELECTIVE GENE-TRANSFER; II MALIGNANT-MELANOMA; AVIAN INFLUENZA-VIRUS; COLORECTAL-CANCER;
D O I：
10.2217/FMB.12.4
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Newcastle disease virus (NDV) is an avian paramyxovirus, which has been demonstrated to possess significant oncolytic activity against mammalian cancers. This review summarizes the research leading to the elucidation of the mechanisms of NDV-mediated oncolysis, as well as the development of novel oncolytic agents through the use of genetic engineering. Clinical trials utilizing NDV strains and NDV-based autologous tumor cell vaccines will expand our knowledge of these novel anticancer strategies and will ultimately result in the successful use of the virus in the clinical setting.
引用
收藏
页码：347 / 367
页数：21
相关论文
共 50 条
  • [31] Safety and Clinical Usage of Newcastle Disease Virus in Cancer Therapy
    Lam, Han Yuen
    Yeap, Swee Keong
    Rasoli, Mehdi
    Omar, Abdul Rahman
    Yusoff, Khatijah
    Suraini, Abd Aziz
    Alitheen, Noorjahan Banu
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
  • [32] Expressing foreign genes by Newcastle disease virus for cancer therapy
    F. L. Bai
    H. Tian
    Q. Z. Yu
    G. P. Ren
    D. S. Li
    Molecular Biology, 2015, 49 : 171 - 178
  • [33] Expressing foreign genes by Newcastle disease virus for cancer therapy
    Bai, F. L.
    Tian, H.
    Yu, Q. Z.
    Ren, G. P.
    Li, D. S.
    MOLECULAR BIOLOGY, 2015, 49 (02) : 171 - 178
  • [34] Oncolytic Newcastle disease virus expressing the co-stimulator OX40L as immunopotentiator for colorectal cancer therapy
    Tian, Limin
    Liu, Tianyan
    Jiang, Shan
    Cao, Yukai
    Kang, Kai
    Su, Han
    Ren, Guiping
    Wang, Zhenzhong
    Xiao, Wei
    Li, Deshan
    GENE THERAPY, 2023, 30 (1-2) : 64 - 74
  • [35] Newcastle disease virus strain AF2240 as an oncolytic virus: A review
    Kalyanasundram, Jeevanathan
    Hamid, Aini
    Yusoff, Khatijah
    Chia, Suet Lin
    ACTA TROPICA, 2018, 183 : 126 - 133
  • [36] Oncolytic Newcastle disease virus expressing the co-stimulator OX40L as immunopotentiator for colorectal cancer therapy
    Limin Tian
    Tianyan Liu
    Shan Jiang
    Yukai Cao
    Kai Kang
    Han Su
    Guiping Ren
    Zhenzhong Wang
    Wei Xiao
    Deshan Li
    Gene Therapy, 2023, 30 : 64 - 74
  • [37] Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells
    Ke Jiang
    Cuiping Song
    Lingkai Kong
    Lulu Hu
    Guibin Lin
    Tian Ye
    Gang Yao
    Yupeng Wang
    Haibo Chen
    Wei Cheng
    Martin P. Barr
    Quentin Liu
    Guirong Zhang
    Chan Ding
    Songshu Meng
    BMC Cancer, 18
  • [38] Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells
    Jiang, Ke
    Song, Cuiping
    Kong, Lingkai
    Hu, Lulu
    Lin, Guibin
    Ye, Tian
    Yao, Gang
    Wang, Yupeng
    Chen, Haibo
    Cheng, Wei
    Barr, Martin P.
    Liu, Quentin
    Zhang, Guirong
    Ding, Chan
    Meng, Songshu
    BMC CANCER, 2018, 18
  • [39] Oncolytic virus therapy: A new era of cancer treatment at dawn
    Fukuhara, Hiroshi
    Ino, Yasushi
    Todo, Tomoki
    CANCER SCIENCE, 2016, 107 (10) : 1373 - 1379
  • [40] Virulent Velogenic Newcastle Disease Virus Is More Oncolytic Than Attenuated and Lentogenic Newcastle Viruses
    Al-Shammari, Ahmed Majeed
    Hassan, Sarah
    Allawe, Aida Bara
    MOLECULAR THERAPY, 2021, 29 (04) : 7 - 7
12345